CoChat

Mutations in GCK and HNF‐1α explain the majority of cases with clinical diagnosis of MODY in Spain

Estalella, Itziar, Rica, Itxaso, De Nanclares, Guiomar Perez, Bilbao, Jose Ramon, Vazquez, Jose Antonio, San Pedro, Jose Ignacio, Busturia, Maria Angeles, Castaño, Luis, Spanish MODY Group · 2007 · Clinical Endocrinology
Cited by 108

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Objective The aim of this study was to group patients with MODY (maturity‐onset diabetes of the young) according to the genetic alterations underlying the disease and to investigate their clinical characteristics. Patients and methods Molecular analysis of GCK (MODY2), HNF‐1α (MODY3), HNF‐4α (MODY1) and HNF‐1β (MODY5) genes was performed by DNA sequencing in 95 unrelated index probands (47M/48F; mean age 9·9 ± 5·2 years) with clinical diagnosis of MODY. After classification into MODY subtypes according to the genetic alterations, clinical characteristics were compared between the groups. Results Seventy‐six families were shown to carry mutations in GCK (34 of them previously unreported), eight families presented HNF‐1α mutations, and a large genomic rearrangement in HNF‐1β was found in a family. No alteration was found in HNF‐4α. Thus, relative frequencies in the group studied were 80% MODY2, 8·5% MODY3 and 1% MODY5. Comparison of clinical parameters according to genetic status showed significant differences between MODY2 and MODY3 patients in age at diagnosis (9·4 ± 5·4 years vs. 12·7 ± 4·6 years), diagnosis (impaired glucose tolerance vs. diabetes), diagnostic test used (OGTT vs. fasting glucose), treatment (diet and exercise vs. insulin/oral antidiabetic agents) and birth weight (2·96 ± 0·44 kg vs. 3·40 ± 0·67 kg). Conclusion Almost 90% of the MODY cases in the group studied are explained by mutations in the major genes GCK (MODY2) and HNF‐1α(MODY3), although differences in the relative prevalence of each form could be partly due to patient referral bias (paediatric vs. adult). In general, patients with MODY2 were diagnosed at an earlier age in life than MODY3 patients and had a milder form of diabetes. Moreover, the majority of patients with MODY2 mutations were treated with diet whereas half of MODY3 patients received pharmacological treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2007.02921.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 108

Metadata

Authors
Estalella, I., Rica, I., De Nanclares, G. P., Bilbao, J. R., Vazquez, J. A., San Pedro, J. I., Busturia, M. A., Castaño, L., & Spanish MODY Group
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2007-05-24
Volume
67
Issue
4
Pages
538-546
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2020156658
Cited by
108
References
2
FWCI
4.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutations in GCK and HNF‐1α explain the majority of cases with clinical diagnosis of MODY in Spain. https://app.cochat.ai/papers/10.1111/j.1365-2265.2007.02921.x
The paper
Estalella, I., Rica, I., De Nanclares, G. P., Bilbao, J. R., Vazquez, J. A., San Pedro, J. I., Busturia, M. A., Castaño, L., & Spanish MODY Group. (2007). Mutations in GCK and HNF‐1α explain the majority of cases with clinical diagnosis of MODY in Spain. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2007.02921.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.